Menu Back to Advertising-and-Promotion-Regulatory-Affairs-Conference


Conference: March 12-13, 2024

DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.

This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for professional development, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory agencies, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.

While we develop our 2024 agenda, please take a moment to review the 2023 final agenda.


Want to learn more about Advertising and Promotion Regulatory Affairs Conference? You've come to the right site!
DIA Global Annual Meeting


Learn more
Generic Highlights

Highlights & Features

Learn more

Who should attend?

  • Meeting Designed For

    Join professionals from every corner of the vast realm of Advertising and Promotion Regulatory Affairs:

    • Regulatory Affairs
    • Marketing
    • Communications
    • Compliance
    • Medical Information and Affairs
    • Legal
    • Patient Engagement

Program Committee

  • Alyson  Andrikanich, PharmD
    Alyson Andrikanich, PharmD Senior Director, Advertising and Promotion, Regulatory Affairs Americas
    Bayer Pharmaceuticals, United States
  • Lynn  Bowen, PhD
    Lynn Bowen, PhD Vice President, Regulatory Affairs Advertising Promotion & Labeling
    Alkermes, Inc., United States
  • Bob  Dean, MBA
    Bob Dean, MBA Head of Global Labeling Strategy & Ad/Promo
    EMD Serono, United States
  • Anthony  Genovese
    Anthony Genovese Group Leader, Regulatory Advertising and Promotion
    Johnson and Johnson, United States
  • Nicol Lorraine George, PharmD, RPh
    Nicol Lorraine George, PharmD, RPh Vice President, Promotional & Labeling Services
    ProPharma Group, United States
  • Catherine  Gray, PharmD
    Catherine Gray, PharmD Director, Office of Prescription Drug Promotion, OMP, CDER
    FDA, United States
  • Joanne  Hawana, JD, MS
    Joanne Hawana, JD, MS Member
    Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States
  • Georgina  Lee, PharmD
    Georgina Lee, PharmD Executive Director, Regulatory Advertising and Promotion
    Sage Therapeutics, United States
  • Amy  Muhlberg, PhD
    Amy Muhlberg, PhD Deputy Director, OPDP’s Division of Promotion Policy, Research and Operations
    FDA, United States
  • Moulakshi  Roychowdhury, JD, PharmD
    Moulakshi Roychowdhury, JD, PharmD Global Head, Regulatory Affairs, Advertising & Promotion, Allergan Aesthetics
    AbbVie, United States
  • Dale  Cooke, JD, MA
    Dale Cooke, JD, MA President
    PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos Vice President & Global Head, Advertising, Promotion & Labeling
    Sanofi, United States
  • Micheline  Awad, MBA
    Micheline Awad, MBA Senior Director, Regulatory Affairs - Advertising, Promotions, and Labeling
    Turning Point Therapeutics, Inc., A Bristol Myers Squibb Company, United States
  • Representative Invited
    Representative Invited DIA, United States
Load More

Contact us

Digital Learning Catalog

DIA Learning: eLearning Soultions